We are live on ! Find out more
OCA

OpenArc Corporate Advisory Portfolio holdings

AUM $8.41B
This Fund
S&P 500
This Quarter Est. Return
+16.96%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$8.41B
AUM Growth
+$1.42B
Cap. Flow
+$539M
Cap. Flow %
6.42%
Top 10 Hldgs %
33.46%
Holding
833
New
117
Increased
380
Reduced
255
Closed
44
Avg Time Held
1.6 quarters
Top 10 Avg Time Held
1.6 quarters
Top 20 Avg Time Held
1.7 quarters

Sector Composition

Rank Sector Weight
1 Miscellaneous 58.82%
2 Technology 16.24%
3 Consumer Discretionary 5.63%
4 Healthcare 3.98%
5 Industrials 3.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
XCOR icon
651
FundX ETF
XCOR
$186M
$276K ﹤0.01%
+3,042
New +$263K
2026 Q2
0 quarters
ERIC icon
652
Ericsson
ERIC
$30.5B
$275K ﹤0.01%
24,703
+6,332
+34% +$76.3K
2026 Q1
1 quarter
WDAY icon
653
Workday
WDAY
$45.4B
$275K ﹤0.01%
+2,249
New +$285K
2026 Q2
0 quarters
DB icon
654
Deutsche Bank
DB
$63.2B
$273K ﹤0.01%
8,087
+1,152
+17% +$37.3K
2025 Q4
2 quarters
AVB icon
655
DELISTED
AvalonBay Communities
AVB
$272K ﹤0.01%
1,442
-293
-17% -$53K
2025 Q4
2 quarters
HBAN icon
656
Huntington Bancshares
HBAN
$31.1B
$272K ﹤0.01%
15,338
-2,877
-16% -$47.5K
2025 Q4
2 quarters
BE icon
657
Bloom Energy
BE
$77.2B
$270K ﹤0.01%
+893
New +$229K
2026 Q2
0 quarters
SCHO icon
658
Schwab Short-Term US Treasury ETF
SCHO
$15.4B
$269K ﹤0.01%
11,134
-24,845
-69% -$601K
2025 Q4
2 quarters
OXY icon
659
Occidental Petroleum
OXY
$61.1B
$267K ﹤0.01%
5,506
-76
-1% -$4.32K
2026 Q1
1 quarter
WTW icon
660
Willis Towers Watson
WTW
$27.7B
$266K ﹤0.01%
1,016
+47
+5% +$12.6K
2025 Q4
2 quarters
WTFC icon
661
Wintrust Financial
WTFC
$9.73B
$264K ﹤0.01%
1,641
+12
+0.7% +$1.81K
2025 Q4
2 quarters
FIDI icon
662
Fidelity International High Dividend ETF
FIDI
$386M
$263K ﹤0.01%
+9,626
New +$270K
2026 Q2
0 quarters
RTO icon
663
Rentokil
RTO
$10.2B
$263K ﹤0.01%
9,207
+231
+3% +$7.33K
2026 Q1
1 quarter
UAL icon
664
United Airlines
UAL
$33.9B
$263K ﹤0.01%
+1,932
New +$200K
2026 Q2
0 quarters
AVY icon
665
Avery Dennison
AVY
$12.7B
$263K ﹤0.01%
+1,617
New +$263K
2026 Q2
0 quarters
ROIV icon
666
Roivant Sciences
ROIV
$25B
$261K ﹤0.01%
+7,386
New +$218K
2026 Q2
0 quarters
AX icon
667
Axos Financial
AX
$5.04B
$261K ﹤0.01%
2,683
+9
+0.3% +$811
2025 Q4
2 quarters
PPG icon
668
PPG Industries
PPG
$23.1B
$261K ﹤0.01%
2,154
-3,199
-60% -$356K
2026 Q1
1 quarter
NULV icon
669
Nuveen ESG Large-Cap Value ETF
NULV
$2.59B
$261K ﹤0.01%
5,218
– –
2025 Q4
2 quarters
CPT icon
670
Camden Property Trust
CPT
$11.3B
$260K ﹤0.01%
+2,272
New +$242K
2026 Q2
0 quarters
FBIN icon
671
Fortune Brands Innovations
FBIN
$4.61B
$260K ﹤0.01%
+4,733
New +$190K
2026 Q2
0 quarters
SNPS icon
672
Synopsys
SNPS
$96.3B
$259K ﹤0.01%
581
-46
-7% -$21.6K
2025 Q4
2 quarters
DXJ icon
673
WisdomTree Japan Hedged Equity Fund
DXJ
$2.38B
$256K ﹤0.01%
4,431
+21
+0.5% +$1.18K
2025 Q4
2 quarters
PBF icon
674
PBF Energy
PBF
$10.1B
$256K ﹤0.01%
5,625
+9
+0.2% +$375
2026 Q1
1 quarter
CWI icon
675
State Street SPDR MSCI ACWI ex-US ETF
CWI
$2.88B
$256K ﹤0.01%
6,285
-203
-3% -$8.05K
2025 Q4
2 quarters

Similar funds

OpenArc Corporate Advisory's Q2 2026 Portfolio in Review

As of Q2 2026, OpenArc Corporate Advisory held 833 positions worth $8.41B, up 20% from $6.98B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

OpenArc Corporate Advisory deployed $539M of net new capital in Q2 2026, opening 117 new positions and adding to 380 existing holdings. Its largest new stake was iShares Russell 1000 ETF: 437,245 shares worth $179M.

By sector, the portfolio is most concentrated in Miscellaneous at 59% of assets, up from 57% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was iShares A.I. Innovation and Tech Active ETF, an estimated $119M trimmed.

  • OpenArc Corporate Advisory's largest Q2 2026 buy was iShares Russell 1000 ETF: 437,245 shares worth $179M.
  • OpenArc Corporate Advisory added most to Vanguard Russell 1000 Value ETF in Q2 2026, an estimated $55.3M increase.
  • OpenArc Corporate Advisory's biggest Q2 2026 reduction was iShares A.I. Innovation and Tech Active ETF, cutting an estimated $119M.
  • OpenArc Corporate Advisory fully exited Kiniksa Pharmaceuticals in Q2 2026, selling an estimated $2.33M.
  • OpenArc Corporate Advisory's ten largest holdings make up 33% of its $8.41B portfolio in Q2 2026.
  • OpenArc Corporate Advisory opened 117 new positions and closed 44 in Q2 2026.
  • OpenArc Corporate Advisory's portfolio value rose 20% quarter-over-quarter to $8.41B.

Based on OpenArc Corporate Advisory's 13F filing for Q2 2026, filed 5 Aug 2026.